Stryker to Acquire Artelon, Innovator in Soft Tissue Fixation Solutions

Stryker has announced a definitive agreement to acquire Artelon, a privately held company renowned for its advanced soft tissue fixation products used in foot and ankle surgeries and sports medicine procedures. This strategic acquisition will enhance Stryker’s portfolio in the soft tissue fixation market and demonstrates the company’s ongoing commitment to providing unique and effective solutions for ligament and tendon reconstruction.

Artelon’s proprietary technologies will augment Stryker’s existing product offerings for foot and ankle and sports medicine specialists. The company’s innovative synthetic materials are designed to improve both biological and mechanical reconstruction of ligaments and tendons, with more than 60,000 successful implantations globally. This acquisition enables Stryker to further strengthen its competitive position in the foot and ankle and sports medicine sectors by integrating cutting-edge biomaterial technology that promotes effective healing of soft tissues.

“Artelon’s proven portfolio and unique products will significantly bolster our innovation and service capabilities,” said Tim Lanier, President of Stryker’s Trauma & Extremities division. “By incorporating Artelon’s offerings into our extensive foot and ankle and sports medicine product lines, we aim to provide comprehensive solutions for our customers in these fields. Our shared commitment to integrity, quality, and the advancement of healthcare provider knowledge will drive superior clinical outcomes and help restore patients’ lives.”

en_GBEnglish (UK)